Biotech – a rapid growth journey
While accelerated by the pandemic, biotech was already on a rapid growth journey. Global VC investment in biotech reached an all-time high in 2021 of $41B, a 3.4x increase in five years. By the end of 2021, the combined value of biotech companies globally passed $2.0T, up 5.3x on 2016’s combined total, albeit this total has fallen back by ~5% in the first few months of 2022, due to a public market rout.
Get the full report from Dealroom.co and Danske Bank here